Ceva Santé Animale, a leading global player in the animal health industry, is headquartered in France and operates extensively across Europe, Asia, and the Americas. Founded in 1999, the company has rapidly established itself as a key provider of innovative veterinary products and services, focusing on both companion and livestock animals. Ceva's core offerings include vaccines, pharmaceuticals, and nutritional products, all designed to enhance animal health and welfare. What sets Ceva apart is its commitment to research and development, ensuring that their solutions are not only effective but also tailored to meet the evolving needs of the market. With a strong emphasis on sustainability and animal welfare, Ceva Santé Animale has achieved significant milestones, positioning itself as a trusted partner in the veterinary community.
How does Ceva Sante Animale's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ceva Sante Animale's score of 44 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Ceva Santé Animale reported total carbon emissions of approximately 280,125,000 kg CO2e. This figure includes about 61,773,000 kg CO2e from Scope 1 and 2 emissions, while Scope 3 emissions accounted for approximately 218,352,000 kg CO2e, with purchased goods and services contributing about 114,016,000 kg CO2e. Comparatively, in 2022, the company recorded total emissions of about 250,397,000 kg CO2e, with Scope 1 and 2 emissions at approximately 55,746,000 kg CO2e and Scope 3 emissions at around 194,937,000 kg CO2e. This indicates a rise in emissions from 2022 to 2023. Ceva Santé Animale has not disclosed specific reduction targets or initiatives as part of its climate commitments. The company does not appear to have cascaded emissions data from a parent organization, and there are no reported SBTi (Science Based Targets initiative) reduction targets. Overall, while Ceva Santé Animale has made strides in tracking its emissions, further commitments and reduction strategies may be necessary to align with industry standards for climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | - | - | - |
| Scope 3 | - | 000,000,000 | 000,000,000 |
Ceva Sante Animale's Scope 3 emissions, which increased by 12% last year and increased by approximately 12% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Purchased Goods and Services" being the primary emissions source at 52% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ceva Sante Animale has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.